The Clorox Company (NYSE:CLX) Shares Sold by Reynders McVeigh Capital Management LLC

Reynders McVeigh Capital Management LLC trimmed its stake in The Clorox Company (NYSE:CLX) by 4.8% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,482 shares of the company’s stock after selling 125 shares during the quarter. Reynders McVeigh Capital Management LLC’s holdings in Clorox were worth $381,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the stock. CIBC Private Wealth Group LLC boosted its position in shares of Clorox by 0.5% in the fourth quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after buying an additional 66 shares during the period. Lindbrook Capital LLC increased its stake in shares of Clorox by 6.2% in the first quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock worth $181,000 after purchasing an additional 69 shares during the period. Czech National Bank increased its stake in shares of Clorox by 0.3% in the fourth quarter. Czech National Bank now owns 21,718 shares of the company’s stock worth $3,097,000 after purchasing an additional 71 shares during the period. Modera Wealth Management LLC increased its stake in shares of Clorox by 1.4% in the third quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock worth $672,000 after purchasing an additional 71 shares during the period. Finally, Global Retirement Partners LLC increased its stake in shares of Clorox by 7.2% in the fourth quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock worth $156,000 after purchasing an additional 73 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. DA Davidson restated a “neutral” rating and set a $162.00 price target on shares of Clorox in a research note on Wednesday, April 17th. Citigroup lowered their price target on Clorox from $150.00 to $145.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 10th. Evercore ISI reduced their price objective on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a report on Wednesday, May 1st. Barclays reduced their price objective on Clorox from $136.00 to $132.00 and set an “underweight” rating on the stock in a report on Thursday, May 2nd. Finally, JPMorgan Chase & Co. reduced their price objective on Clorox from $159.00 to $158.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Five research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $144.67.

Clorox Stock Performance

NYSE:CLX traded down $1.59 during mid-day trading on Monday, hitting $134.81. The stock had a trading volume of 368,764 shares, compared to its average volume of 1,238,007. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.14. The stock has a market cap of $16.74 billion, a price-to-earnings ratio of 70.67, a PEG ratio of 2.02 and a beta of 0.39. The company’s 50 day simple moving average is $134.74 and its 200 day simple moving average is $143.21. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90.

Clorox (NYSE:CLX) last released its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business’s revenue was down 5.3% on a year-over-year basis. During the same period in the prior year, the firm earned $1.51 EPS. On average, equities research analysts forecast that The Clorox Company will post 5.91 earnings per share for the current year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.